Sodium (the active ingredient) is a low molecular weight heparin (lmwh).
Prevention of deep vein thrombosis (DVT) and pulmonary embolism (PE) after surgery (especially hip or knee replacement).
Treatment of DVT and PE.
Treatment of unstable angina and nonST-segment elevation myocardial infarction (NSTEMI).
Prevention of blood clots in patients with certain heart conditions.
Lowcap 60mg Inj 0.6ml (Enoxaparin) works by increasing the activity of antithrombin III, a naturally occurring protein that inhibits several clotting factors in the blood. This action helps prevent and treat blood clots.
Store enoxaparin in its original container at room temperature (below 25°C or 77°F). Protect it from light and moisture. Do not freeze. Dispose of unused medication properly.
The dosage of enoxaparin is determined by your doctor and depends on your specific condition and weight.
It is usually injected subcutaneously (under the skin).
Never administer enoxaparin intravenously without specific instructions from your healthcare provider.
Do not reuse needles or syringes.
Injection site reactions (pain, bruising, swelling)
Thrombocytopenia (low platelet count)
Allergic reactions (rash, itching, hives)
Nausea and vomiting
Back pain
Moderate alcohol consumption may increase the risk of bleeding, but avoid excessive alcohol.
Enoxaparin may cause dizziness or drowsiness in some individuals. Avoid driving or operating machinery if affected.
Use only under strict medical supervision. The risks and benefits must be carefully assessed.
Dosage and use are different for children and should be determined by a pediatrician.
Enoxaparin may be less effective in patients with severe kidney disease and may need dose adjustment or alternative treatment.
Generally well-tolerated in patients with liver disease, but monitoring is advisable.
Your doctor or pharmacist
Enoxaparin product monograph (check with your local drug regulatory agency)
